Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve Intimation of the date of Board Meeting
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon has informed stock exchanges that its Board of Directors will meet on Tuesday, November 11, 2025. The key item on the agenda is approval of the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (i.e., Q2 FY26 results). The company has also closed its insider trading window from October 1, 2025 to November 13, 2025, which will reopen on November 14, 2025. No financial figures or business updates have been disclosed in this filing — it is purely a procedural advance notice under SEBI rules.
This is a routine regulatory filing with no direct impact on shareholders. Investors should mark November 11, 2025 on their calendar as the likely date for Biocon's Q2 FY26 earnings announcement, which could drive near-term stock movement depending on the actual numbers.